cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging

Front Immunol. 2023 Feb 28:14:1132653. doi: 10.3389/fimmu.2023.1132653. eCollection 2023.

Abstract

Aging is associated with an increased incidence of autoimmune diseases, despite the progressive decline of immune responses (immunosenescence). This apparent paradox can be explained by the age-related chronic low-grade systemic inflammation (inflammaging) and progressive dysregulation of innate signaling. During cellular aging, there is an accumulation of damaged DNA in the cell's cytoplasm, which serves as ubiquitous danger-associated molecule, promptly recognized by DNA sensors. For instance, the free cytoplasmic DNA can be recognized, by DNA-sensing molecules like cGAS-STING (cyclic GMP-AMP synthase linked to a stimulator of interferon genes), triggering transcriptional factors involved in the secretion of pro-inflammatory mediators. However, the contribution of this pathway to the aging immune system remains largely unknown. Here, we highlight recent advances in understanding the biology of the cGAS-STING pathway, its influence on the senescence-associated secretory phenotype (SASP), and its modulation of the immune system during sterile inflammation. We propose that this important stress sensor of DNA damage is also a trigger of immunosenescence and inflammaging.

Keywords: NF-κB; SASP; aging; cGAS; immunosenescence; inflammaging; senescence.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cellular Senescence / genetics
  • DNA / metabolism
  • Humans
  • Immunosenescence*
  • Inflammation
  • Nucleotidyltransferases / metabolism

Substances

  • DNA
  • Nucleotidyltransferases

Grants and funding

This article was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS), and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES). CS and RM received a scholarship from CAPES. FG and MB are senior investigators from CNPq.